Dr. Kenneth R. Hallows, MD, PhD

Dr. Hallows practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Hallows' NPI, 1043283997, was assigned on February 10, 2006. Dr. Hallows graduated from University of Rochester Medical Center in 1995. Dr. Hallows holds California license C136632.

Dr. Hallows' primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Hallows' primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Hallows is also affiliated with Central Vermont Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Hallows to 1 more hospital, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hallows practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hallows' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hallows is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Hallows' licenses on file in 4 states: California, New York, Vermont and Pennsylvania.

CMS data shows 492 Medicare services from Dr. Hallows across 3 procedure codes in 2024, for 169 Medicare patients. Medicare paid $45,829 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Hallows in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 70% are also on Medicaid. Their average risk score is 6.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hallows' median patient age at 69, with 40% women.

Dr. Hallows accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hallows as offering telehealth.

Dmand AI links 24 papers to Dr. Hallows, published from 2005 to 2021. 2015 was the busiest year, with 4. Dr. Hallows' most frequent co-authors are Mohammad Ali Al-Bataineh, MD, Vivek Bhalla, MD and Dana C. Miskulin, MD.

Dmand AI links Dr. Hallows to 1 clinical trial. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases.

CMS Open Payments shows 23 general payments to Dr. Hallows from 9 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 89% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $11,905.

Dmand AI lists 1 award for Dr. Hallows.

Dr. Hallows graduated from University of Rochester Medical Center in 1995. Dr. Hallows is a member of ASN.

Dr. Hallows is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.